• Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Average Recommendation of "Moderate Buy" from Analysts

    来源: Buzz FX / 21 12月 2024 02:51:11   America/Chicago


    Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat December 21, 2024 Share Link copied to clipboard. Apellis Pharmaceuticals, Inc.
    Read more...
分享